Article Details

Analysts See $0.96 EPS for Acorda Therapeutics, Inc. (ACOR)

Retrieved on: 2018-01-19 17:00:00

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $0.96 EPS for Acorda Therapeutics, Inc. (ACOR). View article details on hiswai:

Excerpt

<div>Whittier Tru Of Nevada Inc has invested 0% in Acorda Therapeutics, Inc. (NASDAQ:ACOR). Blackrock Inc reported 6.28M shares stake. <b>Leucadia National</b> <b>Corporation</b> owns 13,392 shares. Citigroup invested in 71,814 shares. 117,110 are owned by Guggenheim Cap Ltd Limited Liability Company.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up